Erlotinib/Ramucirumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of erlotinib and ramucirumab that may be used in the treatment of epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).

**Synonyms:** - Cyramza/Tarceva - Erlotinib Plus Ramucirumab - Erlotinib and Ramucirumab - Erlotinib-Ramucirumab - Erlotinib-Ramucirumab Regimen - Erlotinib/Ramucirumab - Ramucirumab-Erlotinib - Ramucirumab/Erlotinib - Ramucirumab/Erlotinib Regimen